Biopharma sets new record: $6.6B civil/criminal settlements in 2012, so far
This article was originally published in Scrip
Executive Summary
2012 already is a banner year for drug makers, although the new record set is likely one the industry would prefer to ignore – paying out big bucks to states and the US federal government to settle various charges, such as illegal off-label marketing or overcharging Medicare and Medicaid or other taxpayer-funded health care programs, with firms doling out $6.6 billion as of mid-July, the consumer watchdog Public Citizen reported.
You may also be interested in...
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Clinton's Drug Price Plan: Threat Or Flash In The Political Pan?
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.